Mycobacterium Tuberculosis Ethionamide Resistance Reversion Data

Data from a study on reversing antibiotic resistance in Mycobacterium tuberculosis using the small molecule SMARt-420. The research demonstrates how this molecule circumvents classic ethionamide resistance mutations, restoring drug sensitivity in mice. The dataset supports analysis of a novel mechanism for overcoming multidrug-resistant tuberculosis.

Use Cases

• Analyze the mechanism of ethionamide resistance reversion via the SMARt-420 molecule.
• Study the alternative bioactivation pathway data for ethionamide in Mycobacterium tuberculosis.
• Examine data on the increased basal sensitivity of bacteria to ethionamide following treatment.

Strengths

• Data originates from a peer-reviewed study published in 2020.
• Focuses on a first-of-its-kind molecule (SMARt-420) for reversing antibiotic resistance.
• Addresses a critical global health threat: multidrug-resistant Mycobacterium tuberculosis.

Limitations

• The specific data structure, column names, and sample size are unknown.
• Data is from a single study, limiting generalizability without replication.
• Temporal coverage and geographic scope of the underlying experiments are not specified.

Provenance

Source

Dryad digital repository.

Collection Method

Experimental data from a study on antibiotic resistance reversion.

Freshness

Last updated 2020-06-24.